Interview with Donna Dickenson, emeritus professor of medical ethics and humanities at the University of London. Consumer genetic testing, and subsequent personalized medicine are, by some accounts, the harbingers of a revolution in medicine. In the sphere of pharmacology, this conceit has ethical and practical implications, says international ethics expert Donna Dickenson.Full article: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.151320To request a transcript of this podcast, contact cmajgroup@cmaj.caSubscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.